Continuous Renal Replacement Therapy Market

Partnerships, Collaborations, and Agreements Accounted for the Largest Share of the Overall Growth Strategy Mapped in the Continuous Renal Replacement Therapy (CRRT) Market

The global continuous renal replacement therapy (CRRT) market is expected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. Factors such as clinical advantages of CRRT over intermittent blood purification techniques, increasing global incidence of acute kidney injury, growing number of ICU patients, rising incidence of sepsis, growing prevalence of diabetes and hypertension, and technological advancements are driving the growth of the market.

Partnerships, collaborations, and agreements accounted for the largest share of the overall growth strategy mapped during 2014–2017. Some of the players who adopted this strategy include Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Asahi Kasei Corporation (Japan), Bellco S.r.l. (Italy), and Toray Medical Co., Ltd. (Japan).

The global CRRT market is consolidated in nature. Prominent players in the CRRT market include Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), and Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

In 2016, Baxter International Inc. (U.S.) was the leading player in the CRRT market with its broad range of products and wide geographic reach. The company mainly focused on product development and launches to sustain its leading position in the global CRRT market. The company focused on expanding its CRRT products offering through acquisitions. For instance, Baxter acquired Sweden-based Gambro AB (which offers products for CRRT) in September 2013.

Fresenius Medical Care AG & Co. KGaA (Germany), one of the leading players in the global CRRT market as of 2016, has a strong R&D team and widespread geographic reach with its presence in 120 countries. The company mainly focuses on agreements and partnerships with other players to enlarge its product offerings in the global CRRT market. For instance, the company established partnerships and agreements with CytoSorbents Corporation (U.S.) and Toray Medical Co. Ltd. (Japan) to market and sell their CRRT products in European countries.

Related Reports:

Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
MD 3842
RI Published ON
7/21/2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Continuous Renal Replacement Therapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved